Solid-State Investigation of a Novel (1:2) Venlafaxine-Catechol Cocrystal: Structural, Thermal, Spectroscopic, and Solubility Studies

Abstract This work reports the third cocrystal of venlafaxine (VLF), expanding the limited database of multicomponent solid forms of this clinically important antidepressant. A systematic cocrystal screening is conducted using a mechanochemical method and catechol (CAT) as coformer. The structure of the novel cocrystal is successfully solved from powder X-ray diffraction data, providing detailed insights into its crystal lattice and revealing a venlafaxine-catechol cocrystal in 1:2 stoichiometry. Hirshfeld surface analysis is employed to characterize the distribution and nature of intermolecular interactions within the cocrystal. A binary phase diagram of the system shows the formation of one cocrystal and two eutectic mixtures at different stoichiometric ratios (7:3 and 1:4 (n/n)). All solid forms are further characterized by DSC, PXRD, and FTIR spectroscopy, confirming their distinct structural and chemical features. Solubility studies show that the cocrystal exhibits the highest solubility in comparison to the eutectic mixtures and pure VLF, while the eutectics also enhance solubility relative to the VLF. These results indicate that the enhanced solubilization of the eutectic systems results from the combined effects of CAT-mediated solubilization and solid-state transformations, including in situ formation of the (1:2) VLF-CAT cocrystal, with the extent of these processes depending on the initial solid-state composition. The identification of a novel (1:2) VLF-CAT cocrystal, alongside the characterization of eutectic mixtures, highlights the relevance of cocrystallization strategies for improving the bioavailability, physical stability, and potential therapeutic performance of poorly water-soluble drugs. These findings provide a framework for the rational design of multicomponent solid forms, with implications for future pharmaceutical development and optimization of drug formulations.

Authors

Institutions

Publication Details

Journal
ACS Omega
Published
2026-10-08
DOI
https://doi.org/10.1021/acsomega.6c04465
Primary Topic
Crystallography and molecular interactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Solid-State Investigation of a Novel (1:2) Venlafaxine-Catechol Cocrystal: Structural, Thermal, Spectroscopic, and Solubility Studies

Flávio Júnior Caires, Fábio Furlan Ferreira, Patrícia Osório Ferreira, Giovanna de Paula Costa et al.
ACS Omega
Crystallography and molecular interactions
article

Solid-State Investigation of a Novel (1:2) Venlafaxine-Catechol Cocrystal: Structural, Thermal, Spectroscopic, and Solubility Studies

Flávio Júnior Caires, Fábio Furlan Ferreira, Patrícia Osório Ferreira, Giovanna de Paula Costa, Guilherme Isquibola, Juliana Guedes dos Santos
article en

Abstract

Abstract This work reports the third cocrystal of venlafaxine (VLF), expanding the limited database of multicomponent solid forms of this clinically important antidepressant. A systematic cocrystal screening is conducted using a mechanochemical method and catechol (CAT) as coformer. The structure of the novel cocrystal is successfully solved from powder X-ray diffraction data, providing detailed insights into its crystal lattice and revealing a venlafaxine-catechol cocrystal in 1:2 stoichiometry. Hirshfeld surface analysis is employed to characterize the distribution and nature of intermolecular interactions within the cocrystal. A binary phase diagram of the system shows the formation of one cocrystal and two eutectic mixtures at different stoichiometric ratios (7:3 and 1:4 (n/n)). All solid forms are further characterized by DSC, PXRD, and FTIR spectroscopy, confirming their distinct structural and chemical features. Solubility studies show that the cocrystal exhibits the highest solubility in comparison to the eutectic mixtures and pure VLF, while the eutectics also enhance solubility relative to the VLF. These results indicate that the enhanced solubilization of the eutectic systems results from the combined effects of CAT-mediated solubilization and solid-state transformations, including in situ formation of the (1:2) VLF-CAT cocrystal, with the extent of these processes depending on the initial solid-state composition. The identification of a novel (1:2) VLF-CAT cocrystal, alongside the characterization of eutectic mixtures, highlights the relevance of cocrystallization strategies for improving the bioavailability, physical stability, and potential therapeutic performance of poorly water-soluble drugs. These findings provide a framework for the rational design of multicomponent solid forms, with implications for future pharmaceutical development and optimization of drug formulations.

ACS Omega
Universidade Federal do ABC (BR), Universidade Estadual Paulista (Unesp) (BR)
Openalex Percentile: Top 18%
Crystallography and molecular interactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.